These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15534010)
1. An outcomes-based approach to decisions about drug coverage policies in British Columbia. Morgan S; Bassett K; Mintzes B Psychiatr Serv; 2004 Nov; 55(11):1230-2. PubMed ID: 15534010 [No Abstract] [Full Text] [Related]
5. Using best practices to manage psychiatric medications under Medicaid. Parks J; Surles R Psychiatr Serv; 2004 Nov; 55(11):1227-9. PubMed ID: 15534009 [No Abstract] [Full Text] [Related]
6. Outcomes-based drug coverage in British Columbia. Morgan S; Bassett K; Mintzes B Health Aff (Millwood); 2004; 23(3):269-76. PubMed ID: 15160825 [TBL] [Abstract][Full Text] [Related]
7. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses. Donohue JM Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937 [No Abstract] [Full Text] [Related]
8. Dual eligibles with mental disorders and Medicare part D: how are they faring? Donohue JM; Huskamp HA; Zuvekas SH Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883 [TBL] [Abstract][Full Text] [Related]
9. Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee. Gottlieb D; Dubin WR; Ning A; Gardiner GC Psychiatr Serv; 2004 Nov; 55(11):1210-2. PubMed ID: 15534007 [No Abstract] [Full Text] [Related]
10. Tier 4 drugs and the fraying of the social compact. Lee TH; Emanuel EJ N Engl J Med; 2008 Jul; 359(4):333-5. PubMed ID: 18650510 [No Abstract] [Full Text] [Related]
11. Surprising ways to cut your drug costs: even with insurance you might be paying too much. Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299 [No Abstract] [Full Text] [Related]
12. Prescription drug costs easier to swallow. State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320 [No Abstract] [Full Text] [Related]
13. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Morgan SG; Agnew JD; Barer ML Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641 [TBL] [Abstract][Full Text] [Related]
14. Controlling spending for prescription drugs. Altman SH; Parks-Thomas C N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800 [No Abstract] [Full Text] [Related]
15. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004. Seay M Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309 [No Abstract] [Full Text] [Related]
17. Effectiveness/efficacy difference too often ignored. Silverman E Manag Care; 2013 Jan; 22(1):36. PubMed ID: 23373138 [No Abstract] [Full Text] [Related]
18. Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice. Lagomasino IT; Dwight-Johnson M; Simpson GM Psychiatr Serv; 2005 Jun; 56(6):649-51. PubMed ID: 15939939 [No Abstract] [Full Text] [Related]
19. A prescription for a modern Medicare program. Bach PB; McClellan MB N Engl J Med; 2005 Dec; 353(26):2733-5. PubMed ID: 16382056 [No Abstract] [Full Text] [Related]
20. Drug coverage insurance as a novel element of private health insurance in Poland. Czerw A; Religioni U Acta Pol Pharm; 2013; 70(4):763-7. PubMed ID: 23923401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]